Vitamin Shoppe (VSI) Tops Q4 EPS by 1c

Vitamin Shoppe (NYSE: VSI) reported Q4 EPS of $0.39, $0.01 better than the analyst estimate of $0.38. Revenue for the quarter came in at $293.5 million versus the consensus estimate of $294.17 million.

Comps fell 0.3 percent.

GUIDANCE:

Vitamin Shoppe sees FY2016 EPS of $2.25-$2.45, versus the consensus of $2.35.

For earnings history and earnings-related data on Vitamin Shoppe (VSI) click here.

You May Also Be Interested In

• BrainsWay Ltd. (BWAY) Reports In-Line Q3 EPS, Beats on Revenue; Offers FY26 Revenue Guidance
• Gladstone Land (LAND) Misses Q2 EPS by 6c
• Kamada reports revenue growth in H1 2026, affirms full-year guidance